Ketamine Treatments

Ketamine Therapy is a tremendous opportunity for profound and lasting change. It has helped many people deal with treatment-resistant depression, such as anxiety, OCD, PTSD, bipolar depression, and suicidal ideation. At Stat Health Medical, we do more than just administering Ketamine. Our passionate team is well-trained and experienced in helping patients navigate their psychedelic experiences, maximizing comfort and efficacy. Our team firmly believes that it is not just about taking medicine but how you work with it.

A New Approach to Treatment-Resistant Depression.
Millions of Americans live with depression, and for many, traditional antidepressants don’t bring the relief they need. About one-third of individuals with major depressive disorder (MDD) experience what’s known as treatment-resistant depression (TRD). In these cases, finding an effective treatment can feel overwhelming—but there is hope. Esketamine (Spravato®) is a fast-acting, FDA-approved option that’s bringing real relief to people who haven’t responded to conventional medications.

Esketamine is a medication derived from ketamine and is administered as a nasal spray in a controlled medical setting. It works on different receptors in the brain than traditional antidepressants, targeting the glutamate system to rapidly improve symptoms of depression. Unlike standard medications that can take weeks to show effects, Esketamine often begins working within hours or days.
Approved by the FDA, Esketamine is specifically indicated for treatment-resistant depression and depression with suicidal thoughts, and it must be used alongside an oral antidepressant under clinical supervision.

At Stat Health Medical, Esketamine therapy is individualized for every patient. All treatments are delivered in a quiet, private room under supervision by our trained providers. Each patient is monitored closely during the 2-hour observation period post-administration, and vital signs and mood responses are carefully tracked. We provide a warm, calming atmosphere and professional support throughout your treatment journey.

Conditions We Treat
Our Esketamine nasal spray therapy is used in the treatment of:
• Treatment-Resistant Depression (TRD)
• Major Depressive Disorder (MDD)
• Suicidal ideation associated with depression
• Severe depressive episodes not responding to standard treatments

Esketamine offers a transformative opportunity for those who have not found relief with other options. At Stat Health Medical, our commitment extends beyond administration. Our team supports each patient with education, emotional guidance, and a deep understanding of how to make the most of this breakthrough treatment. We believe true healing is not only about the medicine—it’s also about the people helping you through the process.

The biggest differences between Spravato and IV ketamine are how they’re taken and insurance coverage. Spravato is a self-administered nasal spray used under supervision at a certified clinic, while IV ketamine is administered through an IV. Spravato is usually taken twice a week for four weeks, then once a week or every other week, depending on how well it’s working. IV ketamine is typically given in six sessions over two to three weeks, followed by maintenance treatments as needed. Both treatments work fast, but IV ketamine may take effect even quicker, while Spravato follows a structured, long-term approach with FDA approval.

• Ketamine infusions for psychiatric conditions are $350/per infusion.
• Ketamine infusion for the treatment of depression, anxiety, bipolar disorder, PTSD, postpartum depression, and other psychiatric disorders.
• 40-minute ketamine infusion; plan to be at the clinic for about 1.5 hours per infusion.
• The recommended protocol is 6 infusions during the first 2 weeks of treatment: maintenance infusions on an as-needed basis.
• Effectively alleviates symptoms for up to 70% of patients, including those with severe cases of treatment-resistant depression.
• The ketamine consultation fee is $100, which will be added to the treatment payments if you decide to proceed. You will also receive an additional $200 off if paying for the 6 treatments in full after the initial consultation, for a total of $300 off.

• Esketamine nasal spray (Spravato®) treatments are $350 per session.
• FDA-approved for treatment-resistant depression and depression with suicidal ideation.
• Each session includes a 2-hour clinical observation period, vital sign monitoring, and mental health check-ins.
• The recommended protocol includes twice-weekly treatments for the first 4 weeks, followed by weekly or biweekly sessions for maintenance, depending on patient response.
• Shown to rapidly reduce depressive symptoms in patients who have not responded to traditional antidepressants.
• A one-time consultation fee of $100 is required and will be applied toward treatment costs if you proceed.